ecrin-mdr-crcClinical2003IPD Sharing (as of October 2022): NoColorectal NeoplasmsColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2026348Australia10CapecitabineAntibodiesAntibodies, MonoclonalECRIN MDRCompletedfalseCapecitabine and 131I-huA33 in Patients With Metastatic Colorectal CancerThe purpose of this clinical trial is to determine whether it is safe to treat patients with advanced colorectal cancer, with humanised A33 antibody tagged with radioactive iodine (131I-huA33) in combination with chemotherapy (capecitabine).2003-10-152026348NCT00291486